Cargando…
An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
BACKGROUND: Global ambitions to eliminate malaria are intensifying, underscoring a critical need for transmission blocking tools. In 2012, the WHO recommended the use of 0.25 mg/kg of single low-dose (SLD) primaquine to stop Plasmodium falciparum transmission. To ensure the availability of SLD prima...
Autores principales: | Chen, Ingrid, Poirot, Eugenie, Newman, Mark, Kandula, Deepika, Shah, Renee, Hwang, Jimee, Cohen, Justin M., Gosling, Roly, Rooney, Luke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446184/ https://www.ncbi.nlm.nih.gov/pubmed/25971688 http://dx.doi.org/10.1186/s12936-015-0714-3 |
Ejemplares similares
-
Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014) -
CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019) -
Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022) -
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
por: Stepniewska, Kasia, et al.
Publicado: (2022) -
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria
por: White, Nicholas J, et al.
Publicado: (2014)